Publications by authors named "Matthias Renner"

Claim this Profile
R
Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products.
Brigitte Anliker, Liam Childs, Juliane Rau, Matthias Renner, Silke Schüle

CRISPR J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.
Emmanuel Donnadieu, Maik Luu, Miriam Alb, Brigitte Anliker, Silvia Arcangeli, Matthias Renner

J Immunother Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetically modified regulatory T cells: therapeutic concepts and regulatory aspects].
Attila Sebe, Brigitte Anliker, Juliane Rau, Matthias Renner

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.
Simone Gabner, Reinhard Ertl, Karsten Velde, Matthias Renner, Florien Jenner

J Gene Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach.
Angela M Krackhardt, Brigitte Anliker, Martin Hildebrandt, Michael Bachmann, Stefan B Eichmüller, Matthias Renner

Cancer Immunol Immunother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment.
Mohamed Abou-El-Enein, Toni Cathomen, Zoltán Ivics, Carl H June, Matthias Renner

Cell Stem Cell· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo study.
Juraj Hlavatý, Zbyněk Tonar, Matthias Renner, Sylvia Panitz, Helga Petznek

Histochem Cell Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side.
Michael Hudecek, Zsuzsanna Izsvák, Sandra Johnen, Matthias Renner, Gabriele Thumann

Crit Rev Biochem Mol Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products.
Takao Hayakawa, Ian Harris, Jeewon Joung, Nobuo Kanai, Shin Kawamata, Matthias Renner

Biologicals· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation-induced transgene expression in genetically engineered equine mesenchymal stem cells.
Simone Gabner, Juraj Hlavaty, Karsten Velde, Matthias Renner, Florien Jenner

J Gene Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
Matthias Renner, Brigitte Anliker, Ralf Sanzenbacher, Silke Schuele

Adv Exp Med Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
Paula Salmikangas, Martina Schuessler-Lenz, Sol Ruiz, Patrick Celis, Ilona Reischl, Matthias Renner

Adv Exp Med Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic approaches using genetically modified cells].
Brigitte Anliker, Matthias Renner, Matthias Schweizer

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell therapy clinical trials in Germany--Critical aspects of quality data content: Summary of meeting presentation.
Matthias Renner

Biologicals· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
Patrick Wuchter, Karen Bieback, Hubert Schrezenmeier, Martin Bornhäuser, Lutz P Müller, Matthias Renner

Cytotherapy· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV.
Mohamed Abou-El-Enein, Gerhard Bauer, Petra Reinke, Matthias Renner, Christian K Schneider

Trends Mol Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis.
Alessandro Aiuti, Giulio Cossu, Pablo de Felipe, Maria Cristina Galli, Gopalan Narayanan, Matthias Renner

Hum Gene Ther Clin Dev· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.
Juraj Hlavaty, Helga Petznek, Harry Holzmüller, Angelika Url, Gerrit Jandl, Matthias Renner

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety assessment of biolistic DNA vaccination.
Barbara Langer, Matthias Renner, Jürgen Scherer, Silke Schüle, Klaus Cichutek

Methods Mol Biol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.
Matthias Paar, Dieter Klein, Brian Salmons, Walter H Günzburg, Matthias Renner

BMC Mol Biol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors.
Daniel Portsmouth, Daria Deitermann, Brian Salmons, Walter H Günzburg, Matthias Renner

J Virol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Matthias Paar, Sonja Schwab, Doris Rosenfellner, Brian Salmons, Walter H Günzburg, Matthias Renner

J Virol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis